Search Results - "Moreo, G"

Refine Results
  1. 1

    Efficacy ozone therapy in reducing oral infection of periodontal disease: a randomized clinical trial by Moreo, G, Mucchi, D, Carinci, F

    “…Periodontal diseases are among the most common infectious diseases in the world, caused by pathogenic bacteria that trigger innate, inflammatory, and adaptive…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Visual evoked potentials in NIDDM : a longitudinal study by MOREO, G, MARIANI, E, PIZZAMIGLIO, G, COLUCCI, G. B

    Published in Diabetologia (01-05-1995)
    “…In order to assess the possible progression of neurological abnormalities over time and the value of visual evoked potential alterations in predicting…”
    Get full text
    Journal Article
  4. 4

    Study of visual evoked potentials in diabetics without retinopathy: correlations with clinical findings and polyneuropathy by Mariani, E, Moreo, G, Colucci, G B

    Published in Acta neurologica Scandinavica (01-04-1990)
    “…To evaluate central optic pathways' involvement in diabetics, visual evoked potentials (VEP), in particular the latency of positive peak (LP100), were studied…”
    Get more information
    Journal Article
  5. 5

    RV11 (propionyl erythromycin mercaptosuccinate) pharmacokinetics in bronchial secretions by Concia, E, Marone, P, Moreo, G C, Sardi, C, Braschi, R

    Published in Journal of international medical research (01-01-1986)
    “…The kinetics of RV11 (propionyl erythromycin mercaptosuccinate) in serum and bronchial secretions was investigated in heterogeneous bronchopneumopathic…”
    Get more information
    Journal Article
  6. 6

    High heparin released platelet factor 4 in uncomplicated type 1 diabetes mellitus by Cortellaro, M, Cofrancesco, E, Vicari, A, Boschetti, C, Della Volpe, A, Moreo, G, Pozza, G, Polli, E E

    Published in Thrombosis research (15-06-1990)
    “…The role of platelet activation in diabetic microangiopathy is still controversial. We evaluated the degree of platelet activation in relation to vessel wall…”
    Get more information
    Journal Article
  7. 7

    Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers by GIULIDORI, P, CORTELLARO, M, MOREO, G, STRAMMENTINOLI, G

    Published in European journal of clinical pharmacology (01-01-1984)
    “…S-Adenosyl-L-methionine (AdoMet) kinetics was studied in 6 male subjects given 100 and 500 mg i.v. Drug concentrations in plasma and urine were assayed using a…”
    Get full text
    Journal Article
  8. 8

    Alpha-2 antiplasmin in acute nonlymphoblastic leukemia by Cofrancesco, E, Pogliani, E, Salvatore, M, Moreo, G, Boschetti, C, Cortellaro, M

    Published in Acta haematologica (01-01-1989)
    “…The levels of alpha-2-antiplasmin (alpha 2-AP), antithrombin III (At III) and plasminogen were studied in 21 patients with acute nonlymphoblastic leukemia…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis by Pozzi, E, Dolcetti, A, Orlandi, O, Cirianni, C, Moreo, G, Piacenza, G, Rampulla, C, Fugazza, L, Scarpazza, G

    Published in Arzneimittel-Forschung (01-12-1994)
    “…A multicentre double-blind placebo-controlled study was conducted in order to assess the effects of pidotimod ((R)-3-[(S)-(5-oxo-2-pyrrolidinyl)…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20